Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02867046
Other study ID # 4-2016-0442
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 29, 2016
Est. completion date November 28, 2016

Study information

Verified date May 2018
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Lumbosacral transforaminal epidural steroid injection (TFESI) is helpful for the treatment of lumbosacral radicular pain, but in case of intravascular injection, infrequently serious complication can be developed. Against this backdrop, if there is any difference of frequency of intravascular injection incidence during S1 (sacrum 1) TFESI between method using medial approach and method using lateral approach in anteroposterior view, the result can be crucial factor in selecting the approach. In addition, appropriate volume of injection will be checked in each approach.


Recruitment information / eligibility

Status Completed
Enrollment 165
Est. completion date November 28, 2016
Est. primary completion date November 28, 2016
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

1. Adult patients (20-80 years of age) who were scheduled to receive S1 transforaminal epidural steroid injection for lumbosacral radicular pain at pain management clinic

Exclusion Criteria:

1. pregnancy

2. coagulopathy

3. systemic infection

4. any active infection at the injection site

5. history of allergy to contrast media, local anesthetics, corticosteroid

6. patients unable to communicate or patients with cognitive dysfunction

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
S1 transforaminal epidural steroid(dexamethasone) injection
medial approach group (n=85): check intravascular injection while performing S1 transforaminal epidural steroid(dexamethasone) injection in medial side of S1 foramen under fluoroscopy lateral approach group (n=85): same as medial approach group except using lateral side of S1 foramen

Locations

Country Name City State
Korea, Republic of Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary the incidence of intravascular injection in the medial approach group in S1 foramen 5 seconds after injection of contrast media via block needle.
Primary the incidence of intravascular injection in the lateral approach group in S1 foramen 5 seconds after injection of contrast media via block needle.
See also
  Status Clinical Trial Phase
Terminated NCT03057197 - The Influence of Needle-insertion Depth on Successful Epidurogram and Clinical Outcome in Caudal Epidural Injections N/A
Completed NCT01926470 - The Incidence of the Intravascular Injection During S1 Transforaminal Epidural Steroid Injection in Two Approaches: Anteroposterior Versus Oblique N/A
Completed NCT03613662 - A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 Phase 2
Completed NCT03372161 - Corticosteroid Lumbar Epidural Analgesia for Radiculopathy Phase 3